Framingham, MA, United States of America

Chuehling Kuo

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tufts University. Active years: 2013.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Chuehling Kuo in Toxin Delivery Methods

Introduction

Chuehling Kuo is an accomplished inventor based in Framingham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of toxin delivery methods. His innovative work has the potential to enhance drug development processes and improve cell-based assays.

Latest Patents

Chuehling Kuo holds a patent for "Methods for the delivery of toxins or enzymatically active portions thereof." This invention relates to methods, systems, and kits designed for intoxicating both neuronal and non-neuronal cells with a toxin or its fragments. The process involves subjecting a toxin substrate and a lipid or polymeric carrier, such as a DNA uptake facilitating agent, to one or more cells. This method allows for high throughput assays, facilitating the evaluation of drug candidates effectively.

Career Highlights

Kuo is affiliated with Tufts University, where he continues to advance his research in biotechnology. His work is characterized by a focus on innovative methods that can significantly impact the field of drug development and cellular biology.

Collaborations

Chuehling Kuo has collaborated with notable colleagues, including Charles Bix Shoemaker and George A Oyler. These collaborations have contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Chuehling Kuo's innovative contributions to toxin delivery methods exemplify the intersection of biotechnology and drug development. His work not only enhances our understanding of cellular interactions but also paves the way for future advancements in therapeutic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…